|
EORTC AISBL / IVZW |
|
|
EORTC AISBL / IVZW |
Open studies are marked with a purple background, closed studies have a grey background, studies to be opened have a white background
| 08013 | Phase II study with Gefitinib (sequentially) following Gemcitabine/Cisplatin as induction regimen for patients with stage IIIA N2 NSCLC |
| 22994 | A Phase I Study on the Feasibility of High Dose Three-Dimensional Conformal Radiotherapy in Patients with Inoperable and Locally Advanced Non Small Cell Lung Cancer. |
| 08981 | Surgical treatment of stage IIIB non-small cell lung cancer after induction chemo-radiotherapy. |
| 22993 | EORTC Study 22993-08993 Prophylactic cranial irradiation in extensive disease small cell lung cancer. (A joint study with the EORTC Radiotherapy and Lung Cancer Groups) |
| 16996SL | Open label phase II study on RFS 2000 (9-nitro-camptothecin,9NC) administered as a "5days on-2days off"oral treatment in advanced small cell lung cancer eortc study 16996SL |
| 08984 | Taxotere and Cisplatin as induction chemotherapy in patients with stage IIIa N2 non small cell lung cancer (NSCLC) |
| 16994N | Open label phase II study on Glufosfamide administered as a 60 minute infusion every 3 weeks in advanced non small cell lung cancer: EORTC study 16994N |
| 08971b | Survival in an international phase III prospective randomized LD small cell lung cancer vaccination study with adjuvant BEC2 and BCG |
| 08972 | Randomized phase III study comparing induction chemotherapy to daily low dose cisplatin both combined with high dose radiotherapy in patients with inoperable non-small cell lung cancer stage I, II and (low volume) stage III. |
| 08975 | Randomised study with new combination chemotherapies in advanced non-small cell lung cancer. |
| 08971 | Survival in an international phase III prospective randomized LD small cell lung cancer vaccination study with adjuvant BEC2 and BCG |
| 08965 | Temozolomide in advanced non-small cell lung cancer with and without brain metastases: Phase II |
| 08962 | A phase III study of Marimastat in patients with small cell lung cancer following a response to first line chemotherapy. |
| 08956 | Phase II study on Taxol in bronchioalveolar carcinoma |
| 08958 | Phase II study on Carboplatin and Taxol as induction regimen in stage IIIa (N2) non-small cell lung cancer (NSCLC) |
| 08957 | Phase II study on Topotecan in combination with Cisplatin as second line treatment of small cell lung cancer |
| 08961 | Phase II study of VIP (Etoposide, Ifosfamide and Cisplatin) in the treatment of invasive thymoma (In collaboration with ECOG, SWOG and CALGB) |
| 08951 | Phase III trial on sequential radiotherapy with or without daily Cisplatin in patients with small cell lung cancer limited to chest and good response to induction chemotherapy |
| 08955 | A phase II study of Gemcitabine and Cisplatin as induction regimen in stage IIIa non-small cell lung cancer. |
| 08952 | Adjuvant chemotherapy in completely resected stage I, II, and IIIa non-small cell lung cancer. A prospective randomized Phase III inter-group study (In collaboration with the Adjuvant Lung Project Italy - ALPI) |
| 08941 | Randomized trial of surgery versus radiotherapy in patients with stage IIIa non-small cell lung cancer after a response to induction-chemotherapy. |
| 08923 | A phase III study of standard CDE vs intensified CDE with G-CSF + prophylactic antibiotics in small cell lung cancer |
| 08925 | A randomized trial of two Cisplatin-based combination chemotherapies in advanced non-small cell lung cancer. A phase II study leading to a phase III |
| 08921 | UK02 EORTC/MRC/UKCCCR collaborative randomized phase III study of prophylactic cranial irradiation in patients with small cell lung cancer of limited extent who achieve a complete response to induction chemotherapy |
| ENTA05B | EMPTY |
| 08911 | Phase II trial of oral ifosfamide vs intravenous ifosfamide in advanced non small cell lung cancer |
| 08902 | Phase II trial of suramin in advanced non small cell lung cancer |
| 08891 | The role of radiotherapy in the treatment of brain metastases of small cell lung cancer. A phase II and phase III study |
| 08901 | Etoposide in mesothelioma. A phase II study of cotinuous chemotherapy |
| 08892 | Phase II trial of Navelbine (Vinorelbine) in pretreated patients with small cell carcinoma of the lung |
| 04891 | Essais cliniques phase II d'une nouvelle nitrosourée: la Cystémustine dans les poumons, les adénocarcinomes colo-rectaux, les gliomes, les mélanomes, les reins, les sarcomes des parties molles et les tumeurs de la tête et du cou. |
| 16892S | Phase II trial of 4'-iodo-4'-deoxydoxorubicin in patients with cell lung cancer |
| 16892N | Phase II trial of 4'-iodo-4'-deoxydoxorubicin in patients with non-small cell lung cancer |
| 08883 | Phase III trial on the evaluation of gamma Interferon for intensification/ maintenance of complete or near complete response in small cell lung cancer |
| 08881 | A RANDOMIZED MULTI-CENTRE STUDY TO COMPARE THE EFFICACY AND TOLERABILITY OF ICS 205-930 WITH A METOCLOPRAMIDE-CONTAINING ANTIEMETIC COCKTAIL FOR THE PREVENTION OF CISPLATIN-INDUCED EMESIS. |
| 08882 | Phase III trial of standard versus alternating chemotherapy in small cell lung cancer, extensive disease |
| 08877 | Alternating versus sequential radio-chemotherapy in limited disease small cell lung cancer; a randomized phase III study |
| 08871 | EUROSCAN: Phase III randomized study of chemoprevention with vitamin A and N-acetylcysteine in patients curatively treated for carcinomas of the larynx, oral cavity and lung (Jointly with the EORTC Head and Neck Cooperative Group : Protocol 24871) |
| 08875 | Phase III randomized trial in metastatic non-small cell lung cancer |
| 07871 | Phase III Randomized Comparison of Intensive Multidrug Chemotherapy with ADR/CTX/VP-16/CACP/DAVA/VCR/MTX with Leucovorin Rescue vs Standard AVE (ADR/VP-16/CTX) in Patients with Small Cell Lung Cancer (Summary Last Modified 05/90) |
| 08873 | E.O.R.T.C. BRONCHIAL COOPERATIVE GROUP TENIPOSIDE FOR BRAIN METASTASES OF SMALL CELL LUNG CANCER. |
| 08872 | PHASE II TRIAL OF ACNU WITH ADVANCED SMALL AND NON-SMALL CELL CARCINOMA OF THE LUNG. |
| 15861 | EORTC STUDY GROUP ON QUALITY OF LIFE PROTOCOL 15861 DEVELOPMENT OF A CORE QUALITY OF LIFE QUESTIONNAIRE FOR USE IN CANCER CLINICAL TRIALS |
| 16864E | Phase II Chemotherapy with Flavone Acetic Acid in Patients with Advanced non-Small Cell Lung Cancer (Summary Last Modified 07/88) |
| 07861 | Phase II Randomized Study Comparing High-Dose CDDP/VP-16 with CBDCA/VP-16 in Patients with non-Small Cell Lung Cancer (Summary Last Modified 05/88) |
| 08863 | CHEMOTHERAPY FOLLOWED BY SURGERY AND RADIOTHERAPY IN NSCLC PATIENTS WITH BIOPSY PROVEN N2 DISEASE. A PHASE II STUDY. |
| 16851C | Phase II Trial of 5-Aza-2'-deoxycytidine in Patients with Advanced Squamous Cell Carcinoma, Adenocarcinoma, and Large Cell Carcinoma of the Lung |
| 08864 | Phase II Chemotherapy with 4'-Epidoxorubicin in Patients with Mesothelioma |
| 08861 | Adjuvant therapy in completely resected lung cancer. A randomized phase III study in operable non-small cell lung cancer (jointly with the EORTC Radiotherapy Cooperative Group) |
| 16853A | Phase II trial of mitozolomide i.v. in patients with advanced small cell lung cancer |
| 08862 | STANDARD COMBINATION CHEMOTHERAPY IN SMALL CELL LUNG CANCER, A PHASE II TRIAL. |
| 08855 | Phase II Chemotherapy with Mitozolomide in Advanced Small and non-Small Cell Carcinoma of the Lung |
| 08854 | PHASE II TRIAL OF 4'-EPIDoxorubicin IN ELDERLY OR UNFIT UNTREATED PATIENTS WITH ADVANCED SMALL CELL CARCINOMA OF THE LUNG. |
| 08853 | Phase II trial of cisplatin-etoposide combination in recurrent or metastatic invasive thymoma |
| 04851 | PHASE II TRIAL OF FOTEMUSTINE IN PATIENTS WITH ADVANCED SOFT TISSUE SARCOMA |
| 08845 | ADJUVANT SURGERY AFTER INDUCTION CHEMOTHERAPY IN LIMITED SMALL CELL LUNG CANCER A RANDOMIZED PROSPECTIVE STUDY. |
| 08844 | Randomized phase III trial comparing radiotherapy + weekly cisplatin vs radiotherapy + daily cisplatin for inoperable non-small cell bronchogenic carcinoma (jointly with the EORTC Radiotherapy Cooperative Group) |
| 08842 | COMBINATION CHEMOTHERAPY + SPLIT-DOSE RADIOTHERAPY, A RANDOMIZED PHASE II STUDY |
| 08843 | Randomized Comparison of Adjuvant Postoperative Combination Chemotherapy with CED (CTX/VP-16/ADR) vs Resection Alone in Patients with Stage I Small Cell Carcinoma of the Lung |
| 08825 | Induction vs induction plus maintenance chemotherapy in SCLC, a phase III trial |
| 22003 | A multicenter randomised trial of high versus standard doses of prophylactic cranial irradiation in limited small cell lung cancer complete responders. (An intergroup study with the PCI99-EULINT Collaborative Group, the EORTC Radiotherapy Group and the EORTC Lung Cancer Group.) |
| 07853 | Randomized Study of Chemotherapy with VP-16/CACP/DAVA vs VP-16/DAVA as Induction Therapy for Small Cell Lung Cancer |
| 08012 | Pre-operative chemotherapy in resectable NSCLC. Randomised trial of surgical resection with or without pre-operative chemotherapy in patients with operable non small cell lung cancer (NSCLC) of any stage. |
| 08021 | A randomized phase III study of follow up with or without adjuvant Gefitinib (Iressa TM) following chemotherapy in patients with advanced Non-Small Cell Lung Cancer. |
| 08092 | Double blind randomized phase III study of maintenance Pazopanib versus placebo in NSCLC patients non progressive after first line chemotherapy. |
| 08072 | Concurrent once-daily versus twice-daily radiotherapy : A 2-arm randomised controlled trial of concurrent chemo-radiotherapy comparing twice-daily and once-daily radiotherapy schedules in patients with limited stage small cell lung cancer (SCLC) and good performance status (CONVERT). |
| 22055 | Phase III study comparing post-operative conformal radiotherapy to no post-operative radiotherapy in patients with completely resected non-small cell lung cancer and mediastinal N2 involvement |
| 08061 | Phase II study of sunitinib (SU11248) in patients with small cell lung cancer who are either chemo-naïve (extensive disease) or have a "sensitive" relapse. |
| 08062 | Randomization phase II study of amrubicin as single agent or in combination with cisplatin versus etoposide-cisplatin as first-line treatment in patients with extensive stage SCLC (ES). |
| 08051 | Randomized Phase II Study Of Pemetrexed And Cisplatin As Either Induction or Adjuvant Chemotherapy In Stage IB-II Non-Small Cell Lung Cancer (NSCLC) |
| 16991N | Open label Phase II study on XR5000 administered as a 5 day infusion in advanced non small cell lung cancer: EORTC study 16991N |
| 16922S | Phase II trial with Topotecan in patients with small cell lung cancer (extensive disease) (In collaboration with the EORTC Lung Cancer Cooperative Group) |
| 16921N | Phase II trial with Taxotere in patients with non-small cell lung cancer |
| 16921S | Phase II trial with Taxotere in patients with small cell lung cancer (extensive disease) |
| 16902L | Phase II trial of Elsamitrucin (BMY 28090) in patients with non-small cell lung cancer |